About
Balancial is working to make lives better
At Balancial we are all about balance. Our name is based upon the core idea that balance is the natural desired state of the body. Our medical cannabis products supports patients reclaiming a natural life balance.

Balancial is entering the Danish market.
Highlights
Balancial is committed to make medical cannabis accessible, safe, and effective across Europe.
Vision
We envision a European market in which medicinal cannabis is available as a safe and a preferred treatment method, changing millions of lives for the better. Every day.

Mission
Through collaboration with industry leaders, our ambition is to provide the highest quality medicinal cannabis products to the European markets. Balancial is working to make lives better.

People
Our team of industry experts work passionately to unfold the potential of medicinal cannabis.

Background from banking and finance, business development, and as an investor. Has in recent years been involved in development, and financing for several start-ups in Norway and internationally. Co-founder of Balancial and has held position as CEO and part of the board in Balancial and its subsidiaries since 2020. Background: BSc, Economics & Administration, specializing in finance.

Daniel has long and broad experience from the financial sector where he held different positions within corporate finance. Since 2017 mr Lunde has served as managing partner at Westpoint Partners, an investment and BD consultancy firm which is the majority shareholder in Balancial. Co-founder of Balancial where he became CFO in 2021. BSc, Economics & Administration, specializing in business development.

Matthias have 15 years experience from managing sales and business development in the German pharmaceutical industry. He comes from the position as Head of Business Unit Services at market leader Cansativa GmbH. In addition to being a certified Paramedic, Matthias holds a Masters degree in Health Economics from the Universities of Cologne and Bremen.

Christine was General Manager at Medizinalcannabis Vertriebs GmbH in Austria, where she played a key role in establishing their Quality Management System and obtaining certifications. With expertise in quality management, cannabinoids, and regulatory affairs, she brings valuable knowledge to her role as COO at Balancial GmbH. She holds university degrees in Chemistry, French, and Pedagogy.

Bo has a background in product development and project management in the pharma industry. He is behind several successful start-ups in the pharmaceutical industry and has been hired as an advisor to, among others, Goldman Sachs and McKinsey in processes related to acquisitions in the pharmaceutical industry. Bo holds a Master’s degree in Pharmaceutical Sciences from the Royal Danish School of Pharmacy.

Ørnulf daily lawyer with his own practice in Bergen. He has extensive experience from several listed companies in roles such as CEO and legal director. He also has experience in international business management and several board positions.

Trine has a broad business background from shipping, marketing, and sales, as well as strategy development and market analysis. Portfolio manager and investor through Teigland Eiendom AS and holds board positions in listed Lifecare.

Bjarte Askeland is a section chief physician in Orthopedic Anesthesia at Haukeland Hospital, and general manager of the Norwegian Anesthesiology Association. Askeland has a master's degree from the Faculty of Medicine, University of Bergen 1979-1985, and has worked as a specialist in anaesthesiology since 1996.

Leif has over 30 years of experience in the pharmaceutical and petrochemical industries. He has extensive expertise in consultancy, business development, line management, and project management. Leif has played a key role in designing process equipment, automating production facilities, and implementing project management models at Novo Nordisk A/S.

Nina holds the regulatory title «Competent Person» and is responsible for Balancial's QMS system. Nina has extensive experience in the pharmaceutical industry, including from Novo Nordisk in Denmark and later as a consultant and consultant. Education: MSc Pharmaceutical Sciences.

Maik brings deep experience in the German medical cannabis market, with an extensive network across pharmaceutical companies, wholesalers, and specialized pharmacies. Most recently, he served as head of pharmacy sales and delivered strong growth. Maik is fluent in German, English, and Spanish, and has international experience from working in over 16 countries. He brings a strategic mindset and hands-on approach to Balancial’s product-sourcing strategy and sales efforts in both Germany and Denmark.”

Marius er ansvarlig for forberedelse af betalinger i bankens system, vedligeholdelse af vores hjemmeside, samt håndtering af vores sociale medieplatforme, herunder LinkedIn, Twitter og Facebook. Derudover koordinerer han samarbejdet med vores reklamebureau og støtter vedligeholdelsen af faciliteterne. Marius udfører også ad hoc-opgaver for at sikre, at vores daglige drift forløber gnidningsfrit.

Carla Ferrao first joined Balancial as GMP Technician but quickly advanced and assumed responsibility for Regulatory Affairs. Prior to joining Balancial Carla worked at the National Food Institute at the Technical University of Denmark. Carla holds a Master’s degree in Chemical Engineering from the University of Southern Denmark.
Investors
Balancial is on a mission to build a medicinalcannabis company with a strong brand, renowned for its high quality

Investor news
Read all